Med spas and aesthetic clinics / Connecticut
Connecticut adds 3 state rules for med spas and aesthetic clinics
Connecticut adds 3 rules to the 21 federal ones the checker already matches to med spas and aesthetic clinics. None of them block approval; all 3 warn. The rules cite Conn. Gen. Stat. 21a-113, Conn. Gen. Stat. 21a-114 and Conn. Gen. Stat. 21a-93.
What Connecticut adds
These are the Connecticut rules whose wording is about injectables, laser, cosmetic procedures and image comparisons. They run when Connecticut is selected in the checker.
CG-CTS-001 · Warns · Citation checked against stored text
The Connecticut Food, Drug and Cosmetic Act deems an advertisement of a drug or device false when it represents the product to have any effect in a list of named diseases, including cancer, diabetes, tumors, high blood pressure and heart disease. The exceptions are ads sent only to health professionals, appearing only in professional journals, or used for public health education by people with no commercial interest.
Source: Conn. Gen. Stat. 21a-114 ("The advertisement of a drug or device representing it to have any effect in albuminuria, appendicitis, arteriosclerosis, blood poison, bone disease"); Conn. Gen. Stat. 21a-93(5) ("the dissemination within this state, in any manner or by any means or through any medium, of any false advertisement")
Safer wording: Do not say a product cures, treats or prevents a named disease in consumer-facing copy. Describe what the product is and what it is cleared or approved for, and send disease-specific information only to health professionals.
Conn. Gen. Stat. 21a-93, Conn. Gen. Stat. 21a-114 · Needs counsel review
CG-CTS-002 · Warns · Citation checked against stored text
Connecticut treats an advertisement of a food, drug, device or cosmetic as misleading when it says or implies the product is recommended or endorsed by a federal or state government agency, unless the agency approved the statement before use.
Source: Conn. Gen. Stat. 21a-113 ("recommended or endorsed by any agency of the federal or state government shall be considered misleading")
Safer wording: Remove agency endorsement language. State only what the agency has actually cleared or approved, in the agency's own words, and keep written approval of the statement on file.
Conn. Gen. Stat. 21a-113 · Needs counsel review
CG-CTS-004 · Warns · Citation checked against stored text
Connecticut deems an advertisement of a drug or device false if it is false or misleading in any particular. No-side-effect, fully-safe and proven-by-trials claims are false in that sense unless the maker can show them.
Source: Conn. Gen. Stat. 21a-113 ("An advertisement of a food, drug, device or cosmetic shall be deemed to be false, if it is false or misleading in any particular")
Safer wording: Replace absolute safety and proof claims with the labeled risks and a cited study, or remove them.
Conn. Gen. Stat. 21a-113 · Needs counsel review
What the checker flags with Connecticut selected
None of our sample wording triggers a Connecticut rule, so no example is shown. The rules above are still part of the set.
The federal rules that still apply
21 federal and general rules matched to med spas and aesthetic clinics run next to the Connecticut ones. The ones that weigh most:
CG-DIS-019 · Blocks approval · Citation checked against stored text
Claims to slow, stop or prevent a serious disease, or to restore function after spinal cord injury, are disease claims that need drug approval and evidence.
Source: FDCA 201(g)(1); 21 CFR 101.93(g); FDA consumer alerts on stem cell and dietary supplement disease claims; FTC Act section 5
Safer wording: Remove disease slowing, prevention and recovery claims. Describe a supplement by its nutrients only, and a stem cell service only as an investigational study.
21 CFR 101.93(g) · Needs counsel review
CG-INF-001 · Blocks approval · Citation checked against stored text
A free product, a commission or a code is a material connection that must be clearly disclosed, and a before-and-after claim by a paid endorser needs proof and a typical-results statement.
Source: FTC Endorsement Guides, 16 CFR Part 255; FTC Rule on Consumer Reviews and Testimonials, 16 CFR Part 465; FTC Act section 5
Safer wording: Put a clear disclosure of any payment, gift or commission at the start of the post, and remove unproven results claims.
16 CFR Part 255, 16 CFR Part 465 · Needs counsel review
CG-RFA-002 · Blocks approval · Citation checked against stored text
Naming a disease as what a product, formula or package is for, or calling something a natural remedy for it, is an implied claim to treat or prevent that disease.
Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance
Safer wording: Do not name a disease as the use of a supplement or cosmetic. Describe general wellness support only.
21 CFR 101.93(g) · Needs counsel review
CG-RFA-003 · Blocks approval · Citation checked against stored text
Anti-cancer, anti-inflammatory, immune-restoring, detox or regenerative claims describe the treatment or mitigation of disease and are unapproved drug claims when made for a supplement, cosmetic or biologic.
Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance
Safer wording: Remove anticancer, anti-inflammatory and regenerative claims. Do not describe the product as acting on disease processes.
21 CFR 101.93(g) · Needs counsel review
Everything for the industry is on the med spas and aesthetic clinics page, and all Connecticut rules for any industry are on the Connecticut page.
Next step
Check your Connecticut med spa copy
Select Connecticut in the checker and every flag cites the rule and source listed above.